Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunometabolic Markers in a Small Patient Cohort Undergoing Immunotherapy
Authors
Keywords
-
Journal
Biomolecules
Volume 12, Issue 5, Pages 716
Publisher
MDPI AG
Online
2022-05-18
DOI
10.3390/biom12050716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Androgen receptor activity in T cells limits checkpoint blockade efficacy
- (2022) Xiangnan Guan et al. NATURE
- Androgen conspires with the CD8 + T cell exhaustion program and contributes to sex bias in cancer
- (2022) Hyunwoo Kwon et al. Science Immunology
- The interplay between cholesterol (and other metabolic conditions) and immune-checkpoint immunotherapy: shifting the concept from the “inflamed tumor” to the “inflamed patient”
- (2021) Melissa Bersanelli et al. Human Vaccines & Immunotherapeutics
- Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
- (2021) Gennadi Tulchiner et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment
- (2021) Jingtao Tong et al. Cancer Management and Research
- Relevance of nutritional assessment and treatment to counteract cardiac cachexia and sarcopenia in chronic heart failure
- (2021) Antía Fernández-Pombo et al. CLINICAL NUTRITION
- Cholesterol Metabolism as a Potential Therapeutic Target and a Prognostic Biomarker for Cancer Immunotherapy
- (2021) Huixian Zhang et al. OncoTargets and Therapy
- Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer
- (2021) Hisao Imai et al. Cancer Medicine
- Cancer cachexia syndrome and clinical outcome in patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors: results from a prospective, observational study
- (2021) Konstantinos Rounis et al. Translational Lung Cancer Research
- Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort
- (2021) G. Fornarini et al. ESMO Open
- Host immune‐inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer and poor performance status receiving first‐line immunotherapy
- (2021) Giuseppe L. Banna et al. Thoracic Cancer
- Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data
- (2021) Sébastien Benzekry et al. Cancers
- Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
- (2020) Daan P. Hurkmans et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
- (2020) Victor C. Kok Frontiers in Oncology
- Targeted deletion of PD-1 in myeloid cells induces antitumor immunity
- (2020) Laura Strauss et al. Science Immunology
- The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors
- (2020) Fabiana Perrone et al. JOURNAL OF IMMUNOTHERAPY
- Loss of testosterone impairs anti-tumor neutrophil function
- (2020) Janet L. Markman et al. Nature Communications
- A high number of PD-L1+ CD14+ monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitors
- (2020) Kiyohiro Ando et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
- (2020) Elisa Peranzoni et al. Frontiers in Immunology
- Circulating CD14highCD16lowintermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression
- (2020) Mélissa Prat et al. Journal for ImmunoTherapy of Cancer
- Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
- (2020) Andressa S Laino et al. Journal for ImmunoTherapy of Cancer
- Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
- (2020) Qingyang Lei et al. Frontiers in Cell and Developmental Biology
- A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
- (2020) Zhipeng Yan et al. Frontiers in Medicine
- Sex and Gender Influences on Cancer Immunotherapy Response
- (2020) Azzurra Irelli et al. Biomedicines
- C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center Study
- (2020) Jakob M. Riedl et al. Cancers
- Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab
- (2020) Giuseppe Luigi Banna et al. Translational Lung Cancer Research
- Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
- (2020) Rilan Bai et al. Biomarker Research
- Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity
- (2020) Niloufar Khojandi et al. Cancer Immunology Research
- Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function
- (2020) Piotr Tymoszuk et al. Frontiers in Oncology
- Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment
- (2019) Xingzhe Ma et al. Cell Metabolism
- Impact of cholesterolemia and body mass index on outcome of metastatic non small cell lung cancer treated with immunotherapy.
- (2019) Giulia Galli et al. JOURNAL OF CLINICAL ONCOLOGY
- The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
- (2019) April E. Mengos et al. Frontiers in Immunology
- Endocrinopathies and cancer cachexia
- (2019) Rony Dev et al. Current Opinion in Supportive and Palliative Care
- Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
- (2019) Xian-Yang Li et al. Cancer Discovery
- Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy
- (2019) Kathrin Renner et al. Cell Reports
- CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
- (2019) Alexandra Landras et al. Cancers
- The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer
- (2019) Eiki Ichihara et al. LUNG CANCER
- Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab
- (2018) Junko Tanizaki et al. Journal of Thoracic Oncology
- Ratio of CD147 high /CD147 low in CD4 + CD25 + T cells: A potential biomarker for early diagnosis and prediction of response to therapy for autoimmune diseases
- (2018) Huifang Guo et al. MEDICAL HYPOTHESES
- High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy
- (2018) Carsten Krieg et al. NATURE MEDICINE
- Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
- (2018) Samuel Rosner et al. Cancer Medicine
- Androgen-Induced Immunosuppression
- (2018) Melanie R. Gubbels Bupp et al. Frontiers in Immunology
- Cholesterol delivery to the adrenal glands estimated by adrenal venous sampling: An in vivo model to determine the contribution of circulating lipoproteins to steroidogenesis in humans
- (2017) Edward Buitenwerf et al. Journal of Clinical Lipidology
- Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
- (2017) Yuko Oya et al. Oncotarget
- Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab
- (2016) Benjamin Weide et al. CLINICAL CANCER RESEARCH
- CD147 modulates androgen receptor activity through the Akt/Gsk-3β/β-catenin/AR pathway in prostate cancer cells
- (2016) Fang Fang et al. Oncology Letters
- The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters
- (2016) Xiaofeng Li et al. Oncotarget
- Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab
- (2016) J. Weber et al. Cancer Immunology Research
- How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
- (2015) G. D. Grass et al. BIOSCIENCE REPORTS
- Effects of Evolocumab on Vitamin E and Steroid Hormone LevelsNovelty and Significance
- (2015) Dirk J. Blom et al. CIRCULATION RESEARCH
- Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet
- (2015) Zhaowei Cai et al. Lipids in Health and Disease
- Function of CD147 in Atherosclerosis and Atherothrombosis
- (2015) Cuiping Wang et al. Journal of Cardiovascular Translational Research
- CD147 in regulatory T cells
- (2013) Johannes Landskron et al. CELLULAR IMMUNOLOGY
- CD147 (Basigin/Emmprin) identifies FoxP3+CD45RO+CTLA4+-activated human regulatory T cells
- (2011) T. Solstad et al. BLOOD
- Functional characterization of human Cd33+ And Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
- (2011) Melissa G Lechner et al. Journal of Translational Medicine
- Peripheral Blood CD14high CD16+Monocytes are Main Producers of IL-10
- (2010) J. Skrzeczyńska-Moncznik et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1:CXCR4 axis
- (2009) A. L. Gomes et al. BLOOD
- Hormonal Regulation of Testicular Steroid and Cholesterol Homeostasis
- (2007) Stephen M. Eacker et al. MOLECULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search